<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Normal pressure hydrocephalus</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Normal pressure hydrocephalus</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Normal pressure hydrocephalus</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Neill R Graff-Radford, MBBCh, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven T DeKosky, MD, FAAN, FACP, FANA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 11, 2020.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Normal pressure hydrocephalus (NPH) refers to a condition of pathologically enlarged ventricular size with normal opening pressures on lumbar puncture. NPH is a form of communicating hydrocephalus and is distinguished from obstructive or noncommunicating hydrocephalus, in which there is a structural blockage of the cerebrospinal fluid (CSF) circulation within the ventricular system (eg, stenosis of aqueduct of Sylvius).</p><p>NPH is associated with a classic triad of dementia, gait disturbance, and urinary incontinence. Because this clinical syndrome is potentially reversible by the placement of a ventriculoperitoneal (VP) shunt, it is important to recognize and diagnose accurately. However, there is little consensus regarding the diagnosis of NPH and the selection of patients for shunt placement, and a sizable minority of patients have evidence of neurodegenerative pathology at the time of shunting or receive a revised diagnosis of Alzheimer disease (AD) or other neurodegenerative dementia within several years of shunting [<a href="#rid1">1</a>]. This is not surprising, as approximately one-third of nondemented adults at the average age of shunt surgery (75 years) have significant AD pathology at the time of autopsy [<a href="#rid2">2</a>].</p><p>This topic provides an overview of the epidemiology, clinical features, diagnosis, and management of NPH. Other dementia syndromes are presented elsewhere. (See  <a class="medical medical_review" href="/d/html/5088.html" rel="external">"Clinical features and diagnosis of dementia with Lewy bodies"</a> and  <a class="medical medical_review" href="/d/html/5085.html" rel="external">"Etiology, clinical manifestations, and diagnosis of vascular dementia"</a> and  <a class="medical medical_review" href="/d/html/5071.html" rel="external">"Clinical features and diagnosis of Alzheimer disease"</a> and  <a class="medical medical_review" href="/d/html/5070.html" rel="external">"Frontotemporal dementia: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>NPH is a rare condition compared with other causes of dementia in older adults, such as Alzheimer disease (AD). The incidence of NPH has varied in different studies from 2 to 20 per million per year [<a href="#rid3">3-6</a>]. These discrepancies probably reflect inconsistent definitions of NPH as well as differences among populations sampled.</p><p>Secondary NPH (those cases associated with an identified etiology) can occur in all age groups. In comparison, idiopathic NPH increases in prevalence with age and is most common in adults over the age of 60 years [<a href="#rid7">7,8</a>]. In one population-based study, the prevalence rose from 0.2 percent in persons 70 to 79 years of age to 6 percent in those over 80 years [<a href="#rid9">9</a>]. It is equally common in both sexes [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H3"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Cerebrospinal fluid (CSF) is produced by the choroid plexus in the lateral ventricles and flows from the lateral ventricles to the third and fourth ventricles, and then through the basal cisterns, tentorium, and subarachnoid space over the cerebral convexities to the area of the sagittal sinus  (<a class="graphic graphic_figure graphicRef57840" href="/d/graphic/57840.html" rel="external">figure 1</a>). CSF is absorbed into the systemic circulation primarily across the arachnoid villi into the venous channels of the sagittal sinus.</p><p class="headingAnchor" id="H4271942650"><span class="h2">Idiopathic NPH</span><span class="headingEndMark"> — </span>When no obvious cause is identified, several possible mechanisms of NPH have been proposed:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decompensated congenital hydrocephalus</strong> – The observation that larger head sizes are more common in patients with NPH than normal controls suggests the possibility that some patients with NPH have congenital hydrocephalus that becomes symptomatic later in life [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent1">Factors that theoretically could aggravate chronic hydrocephalus and cause it to become symptomatic include systemic hypertension, recent head injury, sleep apnea, heart failure, and lung disease (the last three by raising jugular venous pressure and intracranial pressure [ICP]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebrovascular disease</strong> – Hypertension, coronary artery disease, peripheral arterial disease, and other vascular risk factors occur with increased frequency among patients with idiopathic NPH compared with age-matched controls with and without dementia [<a href="#rid14">14-17</a>]. Patients with NPH also have a higher-than-expected prevalence and severity of periventricular white matter disease on magnetic resonance imaging (MRI).</p><p></p><p class="bulletIndent1">These associations have led some to propose that chronic periventricular ischemia leads to increased compliance of the ventricular wall and gradual ventricular enlargement due to normal fluctuations of ICP [<a href="#rid18">18</a>]. Intraventricular pulse pressure and systolic hypertension have also been associated with ventricular enlargement [<a href="#rid19">19</a>]. Alternatively, periventricular ischemia may lead to locally increased venous resistance, which may lead to decreased CSF absorption and ventricular enlargement [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decreased CSF absorption</strong> – Several studies have shown a good correlation between decreased CSF absorption and outcome with shunt surgery [<a href="#rid21">21</a>]. One of the autopsy findings in some patients with NPH is arachnoid thickening, which is present in up to 50 percent of cases [<a href="#rid22">22,23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Increased central venous pressure</strong> – One ultrasound study in 20 patients with idiopathic NPH found that patients were more likely than controls (95 versus 25 percent) to have evidence of retrograde flow in the internal jugular veins during Valsalva [<a href="#rid24">24</a>]. This finding suggests an underlying incompetence of the jugular valves, which, in theory, could lead to increased central venous pressure and impaired CSF absorption.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hydrocephalic presentation of neurodegenerative disorders</strong> – Some patients with NPH are later diagnosed as having a neurodegenerative dementia, or have evidence of "dual pathology" at the time of shunting. Such cases have suggested that neurodegeneration such as Alzheimer disease (AD) may play a role in the ventricular enlargement [<a href="#rid1">1</a>].</p><p></p><p class="headingAnchor" id="H1432708032"><span class="h2">Secondary NPH</span><span class="headingEndMark"> — </span>Impaired absorption of CSF is the suspected mechanism in most cases of secondary NPH.</p><p>The most common identified underlying causes are intraventricular or subarachnoid hemorrhage (either from aneurysm or trauma) and prior acute or ongoing chronic meningitis (from infection, cancer, or inflammatory disease). Paget disease at the skull base, mucopolysaccharidosis of the meninges, and achondroplasia are other rarely reported causes of secondary NPH [<a href="#rid25">25</a>].</p><p>These conditions are understood to cause inflammation and subsequent fibrosis at the base of the brain and/or the arachnoid granulations, and thereby impair CSF resorption. Decreased CSF resorption leads to gradual accumulation of CSF within the ventricular system. While increased pressure is not necessarily measured on lumbar puncture, a pressure effect is nonetheless believed to occur locally on periventricular white matter tracts, producing the observed pathology and clinical symptoms.</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>NPH is classically described as having three cardinal features: gait difficulty, cognitive disturbance, and urinary incontinence [<a href="#rid26">26</a>]. These manifestations are believed to arise from dysfunction of supplementary motor areas of the frontal lobe and periventricular white matter tracts, particularly those subserving frontal lobe connections [<a href="#rid27">27</a>]. Patients need not have all three cardinal features, but gait must be the predominant problem. In other words, a patient can have gait difficulty as the only clinical symptom but cannot have only one of the other two (incontinence or cognitive impairment). Of note, often the earliest urinary problem is urgency rather than incontinence.</p><p class="headingAnchor" id="H2872941112"><span class="h2">Gait dysfunction</span><span class="headingEndMark"> — </span>Gait difficulty is the most prominent clinical feature in NPH [<a href="#rid28">28</a>]. It is also believed to be the clinical feature most responsive to shunting.</p><p>The gait abnormality of NPH is somewhat hard for both patients and clinicians to characterize; it is variably described as a magnetic or "glue-footed" gait, gait apraxia, or a frontal ataxia. Clinicians should not be fixated on these terms when making the diagnosis. Patients with NPH move slowly and take small steps, often with a wide base. They have difficulty turning (eg, they take several steps to turn 180 or 360 degrees) and are most vulnerable to falls when turning. Postural instability demonstrated by the pull test is often present [<a href="#rid29">29,30</a>].</p><p>The parkinsonian gait may bear a resemblance to that of NPH but is distinguished by a narrow base and responsiveness to visual and acoustic cues [<a href="#rid30">30</a>]. Other features of Parkinson disease may also be present, including asymmetry, rest tremor, decreased facial expression, and bradykinesia of the hand and arm movements; these features are usually absent in patients with NPH. (See  <a class="medical medical_review" href="/d/html/4903.html" rel="external">"Clinical manifestations of Parkinson disease", section on 'Cardinal features'</a>.)</p><p>Long tract signs may be observed, with lower-extremity spasticity, hyperreflexia, and extensor plantar responses. In late stages, frontal release signs, akinetic mutism, and quadriparesis may occur.</p><p class="headingAnchor" id="H4147987144"><span class="h2">Cognitive impairment</span><span class="headingEndMark"> — </span>The cognitive disturbance of NPH evolves over months to years and usually develops after the onset of gait dysfunction. Patients typically have both subcortical and frontal features, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Psychomotor slowing</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased attention and concentration</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired executive function</p><p class="bulletIndent1"><span class="glyph">●</span>Apathy</p><p></p><p>Patients may appear depressed but lack depressed thought content. Executive function, the ability to conceptualize all facets of an activity and translate that into appropriate and effective behavior, is impaired early in the course and may be more resistant to treatment [<a href="#rid31">31</a>]. Cortical features (eg, aphasia) are less prominent [<a href="#rid32">32,33</a>].</p><p>The Mini-Mental State Examination and other brief cognitive tests may be an insensitive measure of cognitive impairment in NPH. Other cognitive measures and neuropsychological tests may aid in its characterization. (See <a class="local">'Cognitive evaluation'</a> below.)</p><p class="headingAnchor" id="H401571610"><span class="h2">Urinary incontinence</span><span class="headingEndMark"> — </span>Urinary urgency rather than incontinence may be present at early stages. Also, the gait disorder of NPH delays the patient reaching the bathroom in time. In later stages, urinary incontinence is accompanied by a lack of concern, reflecting its probable origin in frontal lobe impairment.</p><p class="headingAnchor" id="H818618774"><span class="h2">Notable negatives</span><span class="headingEndMark"> — </span>By definition, patients with NPH have a normal opening pressure at the lumbar cistern. The clinical presentation is therefore notable for an <strong>absence</strong> of signs and symptoms related to diffusely increased intracranial pressure (ICP), such as:</p><p class="bulletIndent1"><span class="glyph">●</span>Headaches</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea and vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Visual loss</p><p class="bulletIndent1"><span class="glyph">●</span>Papilledema</p><p></p><p>If performed, findings during lumbar puncture and cerebrospinal fluid (CSF) analysis should be normal; the following are inconsistent with a diagnosis of idiopathic NPH:</p><p class="bulletIndent1"><span class="glyph">●</span>Significantly elevated opening pressure (&gt;25 cm water) [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal CSF profile, including pleocytosis and marked elevation of protein. A mild elevation of protein in isolation is a common nonspecific finding. Pleocytosis requires a rigorous evaluation to determine the underlying etiology. (See  <a class="medical medical_review" href="/d/html/1275.html" rel="external">"Approach to the patient with chronic meningitis", section on 'CSF examination and other laboratory testing'</a>.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>In the absence of a known secondary cause of hydrocephalus, idiopathic NPH is a diagnosis of exclusion that requires careful consideration of neurodegenerative causes of dementia, especially when cognitive impairment is a prominent symptom. In particular, neurodegenerative dementias that include prominent, early gait dysfunction (eg, dementia with Lewy bodies [DLB], progressive supranuclear palsy [PSP]) are important to consider. Since the size of the ventricles increases with age, it is not uncommon for older adults with these dementias to be suspected of having NPH. In such cases, a degree of cortical atrophy accompanying the ventricular enlargement (hydrocephalus ex vacuo) may be helpful in differentiating NPH from neurodegenerative disorders.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dementia with Lewy bodies </strong>– DLB and other parkinsonian disorders are associated with gait abnormalities that bear resemblance to those of NPH (see <a class="local">'Gait dysfunction'</a> above). Additional clinical features that suggest an alternative diagnosis of DLB include prominent psychotic features, especially visual hallucinations, cognitive fluctuations, and rapid eye movement (REM) behavior disorder (RBD)  (<a class="graphic graphic_table graphicRef114309" href="/d/graphic/114309.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/5088.html" rel="external">"Clinical features and diagnosis of dementia with Lewy bodies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parkinson disease dementia</strong> – Cognitive impairment and dementia related to Parkinson disease typically present as a later-stage finding, at a time when typical motor features (eg, tremor, bradykinesia, rigidity) are prominent. Patients with a triad of dementia, gait dysfunction, and urinary incontinence due to Parkinson disease dementia rather than NPH are therefore usually distinguishable by these additional parkinsonian signs. (See  <a class="medical medical_review" href="/d/html/5089.html" rel="external">"Cognitive impairment and dementia in Parkinson disease", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Progressive supranuclear palsy</strong> – PSP is one of the more common revised clinical diagnoses made in patients referred to tertiary clinics for possible NPH [<a href="#rid1">1</a>]. Patients with PSP have voluntary gaze impairment (supranuclear ophthalmoplegia), axial rigidity, and early falls. Although gaze impairment is a hallmark, it may take years to develop, thereby creating diagnostic confusion in the early stages in patients with enlarged ventricles. In addition to eye movement abnormalities, speech and swallowing difficulties are features of PSP that are not present in patients with NPH. (See  <a class="medical medical_review" href="/d/html/14136.html" rel="external">"Progressive supranuclear palsy (PSP): Clinical features and diagnosis", section on 'Clinical characteristics'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multiple system atrophy</strong> – Multiple system atrophy (MSA) is characterized by autonomic dysfunction leading to postural intolerance, bladder or bowel dysfunction, impotence in men, and abnormal sweating. In addition, patients can have either cerebellar ataxia or a parkinsonian form of gait dysfunction. The autonomic features as well as inspiratory stridor, dysarthria, and RBD can help distinguish MSA from NPH. (See  <a class="medical medical_review" href="/d/html/4890.html" rel="external">"Multiple system atrophy: Clinical features and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Corticobasal syndrome</strong> – Clinical features that suggest corticobasal syndrome include an asymmetric presentation of limb rigidity or akinesia, limb dystonia, limb myoclonus, alien limb phenomena, and cortical sensory loss. Although most patients have gait dysfunction and ventricles may appear enlarged due to striatal atrophy, the asymmetric nature of the cortical signs and symptoms usually distinguishes corticobasal syndrome from NPH. (See  <a class="medical medical_review" href="/d/html/14135.html" rel="external">"Corticobasal degeneration", section on 'Clinical features'</a>.)</p><p></p><p>In addition to these syndromes, it is important to consider Alzheimer disease (AD) and cerebrovascular disease, as these conditions are increasingly common with advancing age and therefore commonly coexist with enlarged ventricles. While AD and cerebrovascular disease can coexist with idiopathic NPH, they can also mimic NPH, particularly when other age-related comorbidities exist that may better explain urinary incontinence or gait dysfunction [<a href="#rid35">35</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alzheimer disease</strong> – The average age of patients who undergo shunt surgery for NPH is 70 to 75 years. By this age, autopsy series find evidence of significant Alzheimer pathology in approximately one-third of individuals without clinical dementia [<a href="#rid2">2</a>]. Thus, it is common to have comorbid AD in NPH. While AD itself does not impair gait early in the disease course, gait impairment from a variety of causes is common in older adults and may coexist with AD [<a href="#rid36">36</a>]. Similarly, urinary incontinence from other causes (eg, prostate hypertrophy, pelvic organ prolapse) is common in older adults and may coexist with AD [<a href="#rid37">37</a>]. When dementia starts before the gait abnormality or has features of aphasia, clinicians should suspect AD as the predominant factor in the dementia, rather than NPH [<a href="#rid32">32,33,38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebrovascular disease</strong> – Cerebrovascular disease and vascular risk factors are often comorbid with NPH. In fact, the only double-blind study of shunting for NPH was carried out in 14 patients who were shown to have normal cerebrospinal fluid (CSF) flow dynamics but had evidence of brain vascular disease (eg, severe white matter changes) [<a href="#rid39">39</a>]. All were shunted and randomly assigned to have the shunt open immediately or closed for the first three months. Gait and cognitive scores in the open group improved by approximately 25 to 30 percent compared with the closed group at three months and remained stable at six months. Thus, vascular comorbidity should not dissuade shunt surgery if alternative explanations for the classic NPH triad are not found. (See  <a class="medical medical_review" href="/d/html/5085.html" rel="external">"Etiology, clinical manifestations, and diagnosis of vascular dementia"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>Diagnostic tests are required in the evaluation of patients with clinical evidence of NPH to exclude other conditions, to provide confirmation of the diagnosis, and to identify patients likely to respond to surgical intervention  (<a class="graphic graphic_algorithm graphicRef117418" href="/d/graphic/117418.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H2495591490"><span class="h2">Cognitive evaluation</span><span class="headingEndMark"> — </span>The evaluation of a patient with dementia first establishes the presence of cognitive impairment and provides a measure of its severity. Treatable conditions are excluded. In general, this evaluation includes a brief cognitive assessment and laboratory evaluations (vitamin B12 level and thyroid function tests). This is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/5083.html" rel="external">"Evaluation of cognitive impairment and dementia"</a>.)</p><p>In addition, a formal neuropsychological assessment may provide useful information in the evaluation of patients with NPH. While no single finding or combination of findings is particularly sensitive or specific for NPH or predicts a response to shunting [<a href="#rid10">10</a>], neuropsychological testing can be useful for several reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>It provides a baseline measurement for future comparison, especially after a diagnostic or surgical procedure. The Mini-Mental State Examination may be an insensitive measure of cognitive impairment in NPH, as it does not measure executive function sufficiently.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The characteristic pattern in NPH is that of "frontal-subcortical" dysfunction, in which the patient is slower in timed tasks, performs poorly on tests of divided attention and executive function, has difficulty with fluency tests, and has poor learning and better preserved recognition memory [<a href="#rid31">31,40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It may aid in the diagnosis of comorbid disease (eg, Alzheimer disease [AD] and other causes of dementia). Cortical features (eg, aphasia, apraxia) are atypical for NPH, particularly early in the disease course.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It may also aid in prognosis. The presence of anomia, in particular, has been associated with a lesser benefit from surgery [<a href="#rid32">32,33</a>].</p><p></p><p class="headingAnchor" id="H717095197"><span class="h2">Alternative causes of gait and urinary dysfunction</span><span class="headingEndMark"> — </span>In all patients, alternative causes of gait dysfunction, both neurologic and non-neurologic, should be considered and evaluated, such as:</p><p class="bulletIndent1"><span class="glyph">●</span>Cervical or lumbosacral spondylosis</p><p class="bulletIndent1"><span class="glyph">●</span>Vestibular dysfunction</p><p class="bulletIndent1"><span class="glyph">●</span>Osteoarthritis</p><p class="bulletIndent1"><span class="glyph">●</span>Visual impairment</p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral neuropathy</p><p class="bulletIndent1"><span class="glyph">●</span>Medication side effects (eg, sedatives, antipsychotics)</p><p></p><p>Similarly, neurologic and non-neurologic causes of urinary incontinence should be considered and evaluated. Common causes vary by the type of incontinence:</p><p class="bulletIndent1"><span class="glyph">●</span>Urge incontinence (urinary tract infection, prostatic hypertrophy, myelopathy, neurodegenerative dementias)</p><p class="bulletIndent1"><span class="glyph">●</span>Stress incontinence (pelvic organ prolapse, history of prostate surgery)</p><p class="bulletIndent1"><span class="glyph">●</span>Overflow incontinence (bladder outlet obstruction, prostatic hypertrophy)</p><p class="bulletIndent1"><span class="glyph">●</span>Functional incontinence (decreased mobility combined with other factors such as diabetes, diuretics, other medication side effects)</p><p></p><p>The evaluation of men and women with urinary incontinence is reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/14611.html" rel="external">"Urinary incontinence in men"</a> and  <a class="medical medical_review" href="/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation"</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Magnetic resonance imaging</span><span class="headingEndMark"> — </span>While both magnetic resonance imaging (MRI) and computed tomography (CT) can evaluate ventricular and sulcal size, MRI is superior to CT in the evaluation of patients with possible NPH because it allows visualization of other markers of NPH and provides additional information that can exclude other potential etiologies in the differential diagnosis. However, a CT scan can exclude NPH and is appropriate for screening purposes and in patients who cannot undergo MRI.</p><p class="headingAnchor" id="H9"><span class="h3">Ventriculomegaly</span><span class="headingEndMark"> — </span>The hallmark finding of NPH on CT or MRI is ventriculomegaly in the absence of, or out of proportion to, sulcal enlargement, with no evidence of obstruction at the level of the third or fourth ventricles.</p><p>Ventriculomegaly is considered to be present if the modified Evans ratio is greater than 0.31  (<a class="graphic graphic_diagnosticimage graphicRef117103" href="/d/graphic/117103.html" rel="external">image 1</a>) [<a href="#rid41">41</a>]. This is calculated by measuring the maximal diameter of the frontal horns of the lateral ventricles (at the slice where the frontal horns are largest) to the maximum width of the cranial cavity measured at the inner tables of the skull at the same level.</p><p>Ventriculomegaly is not specific to NPH, however, and the next step is to examine the degree of cortical atrophy to help distinguish NPH from age- or neurodegeneration-related ventricular enlargement (sometimes referred to as hydrocephalus ex vacuo). Ventricular enlargement occurs normally with age as a result of progressive cortical atrophy; the rate of enlargement increases after the age of 60 years [<a href="#rid42">42</a>]. In general, atrophy associated with age or neurodegenerative dementia produces a proportionate enlargement of both ventricular and sulcal size  (<a class="graphic graphic_diagnosticimage graphicRef76428" href="/d/graphic/76428.html" rel="external">image 2</a>).</p><p>Prominent cortical atrophy, as manifested by diffuse sulcal enlargement, argues against the diagnosis of NPH and predicts a lesser likelihood of improvement with shunting  (<a class="graphic graphic_diagnosticimage graphicRef76428" href="/d/graphic/76428.html" rel="external">image 2</a>) [<a href="#rid43">43,44</a>]. In one series, for example, a measurement of the largest sulcus in the frontal or parietal region of less than 1.9 mm was associated with universal improvement with shunting (in all 17 patients), while sulci ≥5 mm were associated with improvement in fewer patients (15 of 27) [<a href="#rid45">45</a>]. Others have also found that sulcal enlargement does not exclude the possibility of improvement with shunting [<a href="#rid25">25</a>].</p><p>Limited data suggest that other qualitative structural MRI findings may aid in identifying ventriculomegaly that is more likely to respond to shunting (ie, NPH). As an example, a group in Japan has coined the term "disproportionately enlarged subarachnoid space hydrocephalus" (DESH) as a characteristic feature of NPH [<a href="#rid46">46</a>]. DESH is characterized by:</p><p class="bulletIndent1"><span class="glyph">●</span>Ventriculomegaly</p><p class="bulletIndent1"><span class="glyph">●</span>Tight high-convexity and medial subarachnoid spaces (easiest to visualize on coronal MRI)  (<a class="graphic graphic_diagnosticimage graphicRef116901" href="/d/graphic/116901.html" rel="external">image 3</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Disproportionate enlargement of the Sylvian fissures</p><p class="bulletIndent1"><span class="glyph">●</span>Focally dilated or entrapped sulci without adjacent cortical atrophy  (<a class="graphic graphic_diagnosticimage graphicRef117105" href="/d/graphic/117105.html" rel="external">image 4</a>)</p><p></p><p>Several observational studies have found that DESH is associated with increased likelihood of response to shunting [<a href="#rid47">47,48</a>], and DESH is incorporated into the Japanese guidelines for NPH [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Periventricular white matter changes</span><span class="headingEndMark"> — </span>In patients with NPH, MRI may show a characteristic high signal abnormality around the ventricles, which is thought to represent transependymal egress of fluid or small blood vessel damage. It is difficult, however, to distinguish this finding from the ubiquitous white matter changes in older adults or from that representing subcortical vascular dementia. The extent of white matter disease may correlate with the degree of cognitive impairment [<a href="#rid31">31</a>]. </p><p>The association between white matter lesions and the response to shunting have been variable. Most studies have found that the more extensive the white matter lesions, the less likely and significant the improvement after shunting [<a href="#rid50">50-52</a>]. However, there are studies showing a good response to shunting in such patients [<a href="#rid44">44,45,53</a>] or no correlation with outcome [<a href="#rid7">7,18,54</a>].</p><p>It is unclear whether the usually poor response to shunting means that extensive white matter disease represents a late stage of NPH no longer amenable to treatment or an alternative pathophysiology (subcortical vascular dementia). In at least two series, there was evidence of reduction of periventricular white matter lesions around the frontal lobes after surgery in patients who improved compared with those who did not, suggesting that the observed white matter changes may, at least in part, represent a reversible, secondary phenomenon of NPH [<a href="#rid53">53,54</a>]. It is also possible that white matter lesions do not cause NPH, but that they commonly coexist [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H11"><span class="h3">Aqueduct flow void</span><span class="headingEndMark"> — </span>MRI in patients with NPH frequently demonstrates loss of signal in the aqueduct of Sylvius, a finding that has been called aqueduct flow void and is thought to represent higher-than-normal flow velocity of cerebrospinal fluid (CSF) in the aqueduct  (<a class="graphic graphic_diagnosticimage graphicRef71397" href="/d/graphic/71397.html" rel="external">image 5</a>). However, this finding is not useful in diagnosis or prediction to response to shunting.</p><p>Multiple studies have found no difference between the extent of flow void in patients with idiopathic NPH compared with age-matched controls, and a poor correlation with postoperative outcome [<a href="#rid55">55-57</a>]. Postoperative clinical improvement is not associated with resolution of this finding [<a href="#rid54">54,58</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Other findings</span><span class="headingEndMark"> — </span>Other findings on MRI may provide evidence of a diagnosis other than NPH that explains or contributes to the patient's clinical syndrome:</p><p class="bulletIndent1"><span class="glyph">●</span>MRI permits better visualization of the posterior fossa than CT, possibly detecting aqueductal stenosis or a Chiari malformation that may cause obstructive hydrocephalus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MRI allows volumetric assessment of medial temporal lobe structures, which may be important because medial temporal atrophy suggests the diagnosis of AD [<a href="#rid59">59</a>]. In two series, medial temporal atrophy, as manifested by either more dilated perihippocampal fissures or as a lower hippocampal volume, was significantly greater in patients with AD compared with NPH [<a href="#rid60">60,61</a>]. Among patients with NPH, one series found a nonsignificant trend between higher hippocampal volumes (ie, less temporal atrophy) and a greater likelihood to benefit from shunting [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MRI is sensitive for the diagnosis of cerebrovascular disease; however, the distinction between transependymal fluid flow and subcortical white matter ischemia is difficult. (See <a class="local">'Periventricular white matter changes'</a> above and  <a class="medical medical_review" href="/d/html/5085.html" rel="external">"Etiology, clinical manifestations, and diagnosis of vascular dementia"</a>.)</p><p></p><p class="headingAnchor" id="H14"><span class="h2">Confirmatory tests</span><span class="headingEndMark"> — </span>Given the invasive nature of the treatment for NPH, and a substantial failure rate, it is generally recommended that an additional test be performed to provide some measure of the patient's likelihood of responding to surgery  (<a class="graphic graphic_algorithm graphicRef117418" href="/d/graphic/117418.html" rel="external">algorithm 1</a>). These tests vary considerably in their invasiveness and requirements for hospitalization and technical expertise, and none have clearly defined sensitivity or specificity [<a href="#rid62">62</a>].</p><p>We use the lumbar tap test, a simple, outpatient procedure, to select patients for surgery. Some institutions prefer inpatient lumbar drain trials. These two tests have gained the most acceptance in the diagnosis of NPH and selection of patients for surgery [<a href="#rid3">3,63</a>].</p><p class="headingAnchor" id="H15"><span class="h3">High-volume lumbar puncture</span><span class="headingEndMark"> — </span>The simplest test can be done as an office procedure. Using lumbar puncture, 30 to 50 mL of CSF is removed with documentation of the patient's gait function before and within 30 to 60 minutes after the procedure. Common parameters measured before and after CSF removal include measures of gait speed, stride length, and number of steps it takes to turn 180 or 360 degrees. We find it useful to make a videotape of the gait before and after the tap. In addition to recording these measures in the office, it is useful to get feedback from the patient and family regarding any subjective improvement over the next few days.</p><p>Documented improvement in one or more of these measures following the procedure suggests that the patient will have a better outcome after placement of a ventriculoperitoneal (VP) shunt [<a href="#rid64">64</a>]. Most studies suggest that this test has excellent positive predictive value (90 to 100 percent), but limited negative predictive value (30 to 50 percent), with a number of patients who show no response to removal of CSF but later improve with surgery [<a href="#rid25">25,65,66</a>]. Others report that this test does not add predictive value over clinical and radiographic criteria [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H2423822348"><span class="h3">Lumbar drain trial</span><span class="headingEndMark"> — </span>An alternative method involves continuous CSF drainage at a rate of 5 to 10 mL/hour via a temporary catheter in the lumbar CSF space. Clinicians, patients, and family members evaluate the clinical response over an observation period in hospital of two to seven days. Clinical improvement after CSF drainage is not associated with change in ventricular size; hence, neuroimaging is not a routine part of this assessment [<a href="#rid68">68</a>]. In small series (&lt;20 patients), this technique has reportedly had 100 percent sensitivity and specificity in predicting subsequent response to shunting [<a href="#rid69">69,70</a>].</p><p>However, others report that, while correctly identifying shunt responders, the negative predictive value is low [<a href="#rid71">71</a>]. In one series, for example, 38 patients with a negative response to lumbar tap underwent lumbar drainage, with an 87 percent positive predictive value for surgical response [<a href="#rid65">65</a>]. However, 63 percent of patients with a negative response improved after shunting.</p><p>Meningitis and subdural hematoma are potential serious complications of these tests, particularly prolonged lumbar drainage [<a href="#rid10">10,65</a>]. These are, in general, rare, but occurred in 2 of 38 patients in one series [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H332352079"><span class="h3">CSF evaluation</span><span class="headingEndMark"> — </span>When either a lumbar puncture or a lumbar drain trial is performed, it is reasonable to send routine diagnostic tests (cell count, protein, glucose) on the CSF when a lumbar puncture is performed in this setting. In most cases of idiopathic NPH, it is expected that these test results will be normal, although a mild elevation of protein in isolation is a common nonspecific finding. Pleocytosis requires a rigorous evaluation to determine the underlying etiology. (See  <a class="medical medical_review" href="/d/html/1275.html" rel="external">"Approach to the patient with chronic meningitis", section on 'CSF examination and other laboratory testing'</a>.)</p><p class="headingAnchor" id="H18"><span class="h3">Cisternography</span><span class="headingEndMark"> — </span>Isotope cisternography consists of injection of a radiolabeled isotope into the lumbar cistern and visualizing its distribution through the cisterns, ventricles, and brain convexities at set time periods following its introduction (4, 24, 48, and 72 hours). NPH is suggested by nonappearance of the isotope over the brain convexities at 72 hours.</p><p>While still often performed in the evaluation of patients with NPH, the utility of this test is limited with poor predictive values for surgical response [<a href="#rid3">3,25,43,50,63,72</a>].</p><p class="headingAnchor" id="H19"><span class="h2">Other tests (not recommended)</span></p><p class="bulletIndent1"><span class="glyph">●</span>CSF biomarkers – There are excellent CSF biomarkers for AD that include low CSF Aβ42 and high phospho-tau levels. Unfortunately, these biomarkers cannot be used to discriminate those with NPH and comorbid AD from those with NPH without AD [<a href="#rid73">73</a>]. The reason is that NPH itself, as well as shunting, may alter biomarker levels [<a href="#rid73">73</a>]. The typical CSF findings in a preshunt NPH patient are low Aβ42 and low phospho-tau. After shunting, levels of both proteins typically increase.</p><p></p><p class="headingAnchor" id="H20"><span class="h1">VENTRICULAR SHUNTING</span><span class="headingEndMark"> — </span>The treatment for NPH is an implanted ventricular shunt.</p><p class="headingAnchor" id="H22"><span class="h2">Patient selection</span><span class="headingEndMark"> — </span>Because of the lack of a gold standard for diagnosing NPH, the limited predictive ability of confirmatory tests, and the invasive nature of implanted shunts, patient selection for shunting is complicated and should be individualized. The absence of any one favorable predictor or the presence of a negative predictor does not rule out the possibility of a shunt response. The predictive values of diagnostic test findings are discussed above. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p>In practice, we suggest ventricular shunting in patients who have typical clinical and imaging findings for NPH, a positive clinical response to a lumbar tap test or lumbar drain trial, and limited or absent negative prognostic indicators  (<a class="graphic graphic_table graphicRef80958" href="/d/graphic/80958.html" rel="external">table 2</a> and <a class="graphic graphic_algorithm graphicRef117418" href="/d/graphic/117418.html" rel="external">algorithm 1</a>).</p><p>The following factors are the most important to consider in assessing the probable response to surgery.</p><p class="bulletIndent1"><span class="glyph">●</span>Dementia – Patients with moderate to severe dementia are unlikely to improve after shunting [<a href="#rid25">25</a>]. This may reflect progression of NPH to an advanced stage in which neurologic injury is fixed or an underlying degenerative dementia such as Alzheimer disease (AD) is the cause of or contributor to the patient's syndrome. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">In two case series that included a cortical biopsy, AD pathology was associated with limited or absent postoperative improvement [<a href="#rid74">74,75</a>]. In comparison, others have suggested that AD pathology is not associated with a poor surgical response, but these studies had a follow-up period of only a few months [<a href="#rid22">22,76</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cause of NPH – Patients with idiopathic NPH have lower rates of improvement after shunt placement compared with patients with a known etiology [<a href="#rid25">25,44,50,72</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Duration of symptoms – Data regarding the preoperative duration of symptoms reveal the strongest association with outcome at the extremes of symptom duration; patients with less than six-month duration have the highest chance of improvement, while those with symptoms, particularly dementia, present for more than two or three years have lower rates of improvement [<a href="#rid7">7,10,32,77</a>]. In one series, dementia present for more than two years was associated with shunt failure in 5 of 7 patients, while 21 of 23 patients with a shorter duration of symptoms improved after surgery [<a href="#rid32">32</a>]. However, others have not found an association between duration of symptoms and surgical response [<a href="#rid21">21,25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Age – Most studies do not find that age influences surgical outcome [<a href="#rid50">50</a>]. However, selection bias may influence these results. In one series, advanced age predicted a worse response to temporary lumbar drainage [<a href="#rid10">10</a>]. However, among the 84 patients with a positive response to lumbar drainage who went on to surgery, age did not influence surgical response.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical manifestations – The relative prominence of the gait disorder versus cognitive impairment, especially early in the course of the syndrome, is felt by many to be associated with surgical outcome [<a href="#rid25">25,32,77</a>]. Late-presenting or no gait disorder predicts a poor surgical outcome in more than 80 percent of patients, while early gait disorder was less strongly predictive of surgical success in 40 to 50 percent [<a href="#rid25">25,43,78</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urinary incontinence – Despite the fact that urinary incontinence is a late sign of NPH, its presence does not clearly impact on a patient's chance of improvement after surgery [<a href="#rid7">7,25</a>].</p><p></p><p class="headingAnchor" id="H504557054"><span class="h2">Efficacy</span><span class="headingEndMark"> — </span>When patients are appropriately selected, shunting for NPH has a sustained effect in one-half to two-thirds of patients with an acceptable complication rate. Supporting evidence is low quality and consists largely of observational studies with relatively short-term follow-up, however.</p><p>A 2013 systematic review identified 64 studies in over 3000 patients with idiopathic NPH, including 27 retrospective studies, 36 prospective observational studies, and 1 randomized trial [<a href="#rid79">79</a>]. The average rate of sustained improvement for three years after shunting was 40 percent in studies in the 1990s, 70 percent in the 2000s, and 73 percent since 2006. The average mortality rate was 9.5 percent in the 1970s and 0.2 percent since 2006. Infection rates decreased from 8.2 percent in the 1970s to 3.5 percent since 2006. The shunt revision rate also decreased from 17.8 percent in the 1970s to 13 percent since 2006.</p><p>Two small, randomized, unblinded crossover trials have examined the value of shunting for idiopathic NPH in selected patients [<a href="#rid39">39,79</a>]. In the larger of the two trials, 93 patients were randomly assigned to immediate lumboperitoneal shunting versus waiting for three months, followed by shunting [<a href="#rid80">80</a>]. The primary endpoint was improvement on the modified Rankin scale (mRS). At three months, 65 percent of those shunted immediately improved by one point or more on the mRS, compared with 5 percent of those not shunted. At one year postshunt, the early and delayed groups had similar rates of improvement (67 and 58 percent). The serious adverse event rate was 15 percent at three months and 28 percent at one year.</p><p class="headingAnchor" id="H23"><span class="h2">Types of shunts</span><span class="headingEndMark"> — </span>Most shunts divert cerebrospinal fluid (CSF) from a catheter in the lateral ventricle into the abdomen (ventriculoperitoneal [VP]) or, less commonly, into the heart (ventriculoatrial). Limited data from Japan indicate that lumboperitoneal shunting may be an effective alternative that does not require cranial surgery [<a href="#rid80">80-82</a>], although larger studies are needed to better determine the safety and efficacy of such shunts compared with the more commonly used VP shunts.</p><p>CSF flow is controlled via a one-way valve in the shunt; many different models of VP shunts are in clinical use [<a href="#rid83">83,84</a>]. Shunts are often classified into low-, medium-, and high-pressure systems. A programmable valve has been developed that allows pressure adjustments without reoperation. In the setting of subdural hematoma, an increase in the pressure setting can aid in hematoma resorption [<a href="#rid63">63</a>]. In patients without a clinical response to shunt placement, the pressure setting can be lowered to increase drainage.</p><p>Studies comparing efficacy and complications of different VP shunts are limited. Most are unblinded comparisons, and mostly retrospective [<a href="#rid85">85</a>]. In general, lower-pressure systems may be slightly more likely to result in clinical benefit than higher-pressure systems, but at the expense of an increased risk for symptomatic overdrainage and subdural hematoma formation. Programmable shunts do not seem to lower the risk of complications compared with fixed-valve shunts, but the ability to titrate to a lower-pressure setting with a programmable valve may result in clinical improvement in some patients. Examples of individual studies include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective comparison of programmable versus standard shunt valves among 407 patients with NPH found a higher incidence of nontraumatic subdural hematoma and hygromas for the programmable valve versus the standard valve (8.5 versus 3 percent) [<a href="#rid84">84</a>]. However, there was no significant difference in the number of surgical decompressions or the number of subsequent surgical shunt revisions (25 versus 23 percent). The cost of implanting a programmable valve was estimated to be three times as much as the standard valve.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A Dutch NPH trial randomly assigned 96 patients with NPH to receive either a low (40 mm H<sub>2</sub>O) or medium-high (100 mm H<sub>2</sub>O) pressure shunt [<a href="#rid86">86</a>]. There was a strong trend toward a higher rate of improvement on a combined measure of gait and cognition in patients receiving a low-pressure shunt (74 versus 53 percent with a medium-pressure shunt, p = 0.06). Subdural effusions were more common in the low-pressure shunt group (71 versus 34 percent), but these did not affect clinical outcome. Unblinded outcome assessments limit the ability to draw firm conclusions from this study.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial that compared a fixed medium-pressure valve setting (120 mm H<sub>2</sub>0) with an initial valve setting of 200 mm H<sub>2</sub>0 that was gradually reduced to 40 mm H<sub>2</sub>0 over a six-month period found a similar rate of shunt complications and overdrainage symptoms in the two groups [<a href="#rid87">87,88</a>]. Efficacy data were available for 55 out of 68 randomized patients (81 percent); in this subset, maximum clinical improvement was seen by three months postoperatively in both groups, and efficacy outcomes were similar between groups. In the adjustable-pressure group, overdrainage was significantly more common with valve settings ≤120 mm H<sub>2</sub>0 than &gt;120 mm H<sub>2</sub>0 (seven versus zero patients). This indicates that a different trial design, in which shunt pressure was only lowered to symptomatic improvement rather than a fixed target pressure, may have resulted in fewer complications in the adjustable-shunt group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective comparison of a flow-regulated shunt system with the more traditional pressure-regulated system found no differences in complication rate, shunt malfunctions, or operative success [<a href="#rid89">89</a>].</p><p></p><p class="headingAnchor" id="H24"><span class="h2">Shunt complications</span><span class="headingEndMark"> — </span>A systematic review of studies of shunting in NPH reported a pooled mean shunt complication rate of 38 percent [<a href="#rid25">25</a>]. Six percent of patients had complications resulting in permanent neurologic sequelae or death and 22 percent required a second surgery. A subsequently published case series that was relatively large (55 patients) reported that 53 percent of their patients required a shunt revision over six years of follow-up [<a href="#rid90">90</a>].</p><p>Shunt overdrainage is the most common complication in the first year, occurring in up to one-third of patients [<a href="#rid25">25,86,91</a>]. Overdrainage may be asymptomatic or present with sustained or postural headaches; radiologic signs of overdrainage range from subdural effusions to subdural hematoma. Serious overdrainage, defined as a symptomatic subdural hematoma requiring surgery, occurs in less than 10 percent of patients and may be more likely in those with a high lumbar puncture opening pressure (eg, &gt;160 mm H<sub>2</sub>O), a large difference between the lumbar and valve opening pressures (eg, &gt;40 mm H<sub>2</sub>O), a high body mass index [<a href="#rid91">91</a>], and use of <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> or other antiplatelet agents [<a href="#rid92">92</a>]. In most cases, subdural hematomas are thought to result from tearing of bridging veins in the setting of shunt overdrainage.</p><p>Other reported complications include:</p><p class="bulletIndent1"><span class="glyph">●</span>Intracranial infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Seizures.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intracerebral hemorrhage from catheter placement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mechanical shunt failures or blocked shunts.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal injury (ascites, peritonitis, abdominal perforations, volvulus) in VP shunts.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Arrhythmias from incorrect distal catheter placement, systemic emboli in ventriculoatrial shunts.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intracerebral hemorrhage is an immediate surgical complication, occurring in 3 to 6 percent of cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Shunt infections usually present within the first month after operation (or reoperation), but can appear later [<a href="#rid90">90</a>]. The manifestations may be quite vague with varying degrees of headache, malaise, nausea, vomiting, and fever. The most common pathogens arise from skin flora.</p><p></p><p class="bulletIndent1">Direct aspiration of CSF from the shunt is often required for diagnosis. Removal of the shunt as well as antibiotic treatment is usually recommended. This topic is discussed separately. (See  <a class="medical medical_review" href="/d/html/1286.html" rel="external">"Infections of cerebrospinal fluid shunts"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Shunt malfunction or suboptimal function may be to blame if a patient fails to improve after surgery [<a href="#rid50">50</a>]. If a programmable valve was placed, lowering the pressure setting to improve drainage may be indicated. Otherwise, lumbar tap tests and CSF infusion tests may be used to determine if shunt revision should be considered [<a href="#rid93">93</a>].</p><p></p><p>While most shunt complications have the highest incidence within the first year, shunt malfunction is an enduring risk [<a href="#rid90">90,94</a>].</p><p>The routine performance of a brain computed tomography (CT) in follow-up has undetermined clinical utility. While ventricular size may decrease postoperatively, studies have mixed results in associating this with postoperative improvement [<a href="#rid74">74</a>]. Thus, CT scan cannot be considered a reliable indicator of shunt functioning. CT scan may also detect a subclinical subdural effusion or hematoma, but as these are unlikely to require treatment, the utility of diagnosing them is uncertain.</p><p>Regular follow-up and attention to symptoms are required. When patients experience neurologic deterioration, a brain CT scan should be performed to exclude the possibility of subdural hematoma and check the catheter position. A shunt series of plain radiographs that visualize the entire shunt system should be performed, looking for visible obstruction. An abdominal ultrasound may also detect obstruction of the shunt tip.</p><p class="headingAnchor" id="H1268959688"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117240.html" rel="external">"Society guideline links: Normal pressure hydrocephalus"</a>.)</p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span><span class="headingEndMark"> — </span>Normal pressure hydrocephalus (NPH) refers to a condition of pathologically enlarged ventricular size with normal opening pressures on lumbar puncture.</p><p class="bulletIndent1"><span class="glyph">●</span>Secondary NPH is most commonly associated with subarachnoid hemorrhage or meningitis, occurs in any age group, and is associated with impaired cerebrospinal fluid (CSF) resorption. Idiopathic NPH is more common in older adults. Its pathogenesis is uncertain. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>NPH is associated with a classic triad of cognitive impairment, gait disturbance, and urinary incontinence. Shunt-responsive NPH is more likely when the gait disturbance appears early on and is more prominent than the cognitive impairment. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The evaluation of a patient with possible NPH includes cognitive assessment and exclusion of alternative causes of gait dysfunction, both neurologic and non-neurologic. (See <a class="local">'Cognitive evaluation'</a> above and <a class="local">'Alternative causes of gait and urinary dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The brain magnetic resonance imaging (MRI) is an essential test in a patient with NPH and demonstrates ventriculomegaly out of proportion to sulcal enlargement and no evidence of CSF flow obstruction. Features of disproportionately enlarged subarachnoid space hydrocephalus (DESH) suggest a good surgical prognosis. Extensive white matter disease and cortical atrophy, particularly involving the medial temporal lobe, are unfavorable indicators. (See <a class="local">'Magnetic resonance imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with clinical and MRI features suggestive of NPH, we use a lumbar tap test to help identify patients likely to respond to shunt placement  (<a class="graphic graphic_algorithm graphicRef117418" href="/d/graphic/117418.html" rel="external">algorithm 1</a>). A lumbar drain trial is preferred by some clinicians. The sensitivity and specificity of these tests are uncertain. (See <a class="local">'Confirmatory tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We suggest ventricular shunting in patients who have clinical and MRI evidence of NPH, a positive test result associated with response to shunting (eg, lumbar tap test), and limited or absent negative prognostic indicators  (<a class="graphic graphic_table graphicRef80958" href="/d/graphic/80958.html" rel="external">table 2</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Patient selection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In selected populations, up to two-thirds of patients can expect some degree of sustained benefit after shunting. Some prognostic indicators may identify those more or less likely to achieve benefit  (<a class="graphic graphic_table graphicRef80958" href="/d/graphic/80958.html" rel="external">table 2</a>). (See <a class="local">'Patient selection'</a> above and <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Shunt complications are common and potentially severe, even fatal, and require vigilance in follow-up on the part of patients and families. (See <a class="local">'Shunt complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Espay AJ, Da Prat GA, Dwivedi AK, et al. Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration. Ann Neurol 2017; 82:503.</a></li><li><a class="nounderline abstract_t">Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18:351.</a></li><li><a class="nounderline abstract_t">Krauss JK, Halve B. Normal pressure hydrocephalus: survey on contemporary diagnostic algorithms and therapeutic decision-making in clinical practice. Acta Neurochir (Wien) 2004; 146:379.</a></li><li><a class="nounderline abstract_t">Tisell M, Höglund M, Wikkelsø C. National and regional incidence of surgery for adult hydrocephalus in Sweden. Acta Neurol Scand 2005; 112:72.</a></li><li><a class="nounderline abstract_t">Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology 2011; 77:1119.</a></li><li><a class="nounderline abstract_t">Kuriyama N, Miyajima M, Nakajima M, et al. Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: Epidemiological and clinical characteristics. Brain Behav 2017; 7:e00635.</a></li><li><a class="nounderline abstract_t">Petersen RC, Mokri B, Laws ER Jr. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology 1985; 35:307.</a></li><li><a class="nounderline abstract_t">Black PM, Ojemann RG, Tzouras A. CSF shunts for dementia, incontinence, and gait disturbance. Clin Neurosurg 1985; 32:632.</a></li><li><a class="nounderline abstract_t">Jaraj D, Rabiei K, Marlow T, et al. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology 2014; 82:1449.</a></li><li><a class="nounderline abstract_t">Marmarou A, Young HF, Aygok GA, et al. Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients. J Neurosurg 2005; 102:987.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR, Godersky JC. Symptomatic congenital hydrocephalus in the elderly simulating normal pressure hydrocephalus. Neurology 1989; 39:1596.</a></li><li><a class="nounderline abstract_t">Krefft TA, Graff-Radford NR, Lucas JA, Mortimer JA. Normal pressure hydrocephalus and large head size. Alzheimer Dis Assoc Disord 2004; 18:35.</a></li><li><a class="nounderline abstract_t">McComb JG, Bradley WG Jr, Safar FG, et al. Is a large hat size hazardous to your health? AJNR Am J Neuroradiol 2004; 25:1454.</a></li><li><a class="nounderline abstract_t">Krauss JK, Regel JP, Vach W, et al. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke 1996; 27:24.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR, Godersky JC. Idiopathic normal pressure hydrocephalus and systemic hypertension. Neurology 1987; 37:868.</a></li><li><a class="nounderline abstract_t">Jaraj D, Agerskov S, Rabiei K, et al. Vascular factors in suspected normal pressure hydrocephalus: A population-based study. Neurology 2016; 86:592.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR. Is normal pressure hydrocephalus becoming less idiopathic? Neurology 2016; 86:588.</a></li><li><a class="nounderline abstract_t">Bradley WG Jr, Whittemore AR, Watanabe AS, et al. Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus. AJNR Am J Neuroradiol 1991; 12:31.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR, Knopman DS, Penman AD, et al. Do systolic BP and pulse pressure relate to ventricular enlargement? Eur J Neurol 2013; 20:720.</a></li><li><a class="nounderline abstract_t">Bradley WG. Normal pressure hydrocephalus: new concepts on etiology and diagnosis. AJNR Am J Neuroradiol 2000; 21:1586.</a></li><li><a class="nounderline abstract_t">Boon AJ, Tans JT, Delwel EJ, et al. Dutch normal-pressure hydrocephalus study: prediction of outcome after shunting by resistance to outflow of cerebrospinal fluid. J Neurosurg 1997; 87:687.</a></li><li><a class="nounderline abstract_t">Bech RA, Waldemar G, Gjerris F, et al. Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochir (Wien) 1999; 141:633.</a></li><li><a class="nounderline abstract_t">Bech RA, Juhler M, Waldemar G, et al. Frontal brain and leptomeningeal biopsy specimens correlated with cerebrospinal fluid outflow resistance and B-wave activity in patients suspected of normal-pressure hydrocephalus. Neurosurgery 1997; 40:497.</a></li><li><a class="nounderline abstract_t">Kuriyama N, Tokuda T, Miyamoto J, et al. Retrograde jugular flow associated with idiopathic normal pressure hydrocephalus. Ann Neurol 2008; 64:217.</a></li><li><a class="nounderline abstract_t">Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. Neurosurgery 2001; 49:1166.</a></li><li><a class="nounderline abstract_t">ADAMS RD, FISHER CM, HAKIM S, et al. SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. N Engl J Med 1965; 273:117.</a></li><li><a class="nounderline abstract_t">Lenfeldt N, Larsson A, Nyberg L, et al. Idiopathic normal pressure hydrocephalus: increased supplementary motor activity accounts for improvement after CSF drainage. Brain 2008; 131:2904.</a></li><li><a class="nounderline abstract_t">Fisher CM. Communicating hydrocephalus. Lancet 1978; 1:37.</a></li><li><a class="nounderline abstract_t">Sudarsky L, Simon S. Gait disorder in late-life hydrocephalus. Arch Neurol 1987; 44:263.</a></li><li><a class="nounderline abstract_t">Stolze H, Kuhtz-Buschbeck JP, Drücke H, et al. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70:289.</a></li><li><a class="nounderline abstract_t">Iddon JL, Pickard JD, Cross JJ, et al. Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study. J Neurol Neurosurg Psychiatry 1999; 67:723.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR, Godersky JC, Jones MP. Variables predicting surgical outcome in symptomatic hydrocephalus in the elderly. Neurology 1989; 39:1601.</a></li><li><a class="nounderline abstract_t">De Mol J. [Prognostic factors for therapeutic outcome in normal-pressure hydrocephalus. Review of the literature and personal study]. Acta Neurol Belg 1985; 85:13.</a></li><li><a class="nounderline abstract_t">Lee SC, Lueck CJ. Cerebrospinal fluid pressure in adults. J Neuroophthalmol 2014; 34:278.</a></li><li><a class="nounderline abstract_t">Malm J, Graff-Radford NR, Ishikawa M, et al. Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 2013; 10:22.</a></li><li><a class="nounderline abstract_t">Sudarsky L, Ronthal M. Gait disorders among elderly patients. A survey study of 50 patients. Arch Neurol 1983; 40:740.</a></li><li><a class="nounderline abstract_t">Temml C, Haidinger G, Schmidbauer J, et al. Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourol Urodyn 2000; 19:259.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR, Godersky JC. Normal-pressure hydrocephalus. Onset of gait abnormality before dementia predicts good surgical outcome. Arch Neurol 1986; 43:940.</a></li><li><a class="nounderline abstract_t">Tisell M, Tullberg M, Hellström P, et al. Shunt surgery in patients with hydrocephalus and white matter changes. J Neurosurg 2011; 114:1432.</a></li><li><a class="nounderline abstract_t">Miyoshi N, Kazui H, Ogino A, et al. Association between cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus. Dement Geriatr Cogn Disord 2005; 20:71.</a></li><li><a class="nounderline abstract_t">Gyldensted C. Measurements of the normal ventricular system and hemispheric sulci of 100 adults with computed tomography. Neuroradiology 1977; 14:183.</a></li><li><a class="nounderline abstract_t">Barron SA, Jacobs L, Kinkel WR. Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology 1976; 26:1011.</a></li><li><a class="nounderline abstract_t">Black PM. Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients. J Neurosurg 1980; 52:371.</a></li><li><a class="nounderline abstract_t">Thomsen AM, Børgesen SE, Bruhn P, Gjerris F. Prognosis of dementia in normal-pressure hydrocephalus after a shunt operation. Ann Neurol 1986; 20:304.</a></li><li><a class="nounderline abstract_t">Børgesen SE, Gjerris F. The predictive value of conductance to outflow of CSF in normal pressure hydrocephalus. Brain 1982; 105:65.</a></li><li><a class="nounderline abstract_t">Kitagaki H, Mori E, Ishii K, et al. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 1998; 19:1277.</a></li><li><a class="nounderline abstract_t">Hashimoto M, Ishikawa M, Mori E, et al. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010; 7:18.</a></li><li><a class="nounderline abstract_t">Shinoda N, Hirai O, Hori S, et al. Utility of MRI-based disproportionately enlarged subarachnoid space hydrocephalus scoring for predicting prognosis after surgery for idiopathic normal pressure hydrocephalus: clinical research. J Neurosurg 2017; 127:1436.</a></li><li><a class="nounderline abstract_t">Mori E, Ishikawa M, Kato T, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo) 2012; 52:775.</a></li><li><a class="nounderline abstract_t">Vanneste JA. Diagnosis and management of normal-pressure hydrocephalus. J Neurol 2000; 247:5.</a></li><li><a class="nounderline abstract_t">Krauss JK, Droste DW, Vach W, et al. Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions. Neurosurgery 1996; 39:292.</a></li><li><a class="nounderline abstract_t">Boon AJ, Tans JT, Delwel EJ, et al. Dutch Normal-Pressure Hydrocephalus Study: the role of cerebrovascular disease. J Neurosurg 1999; 90:221.</a></li><li><a class="nounderline abstract_t">Tullberg M, Hultin L, Ekholm S, et al. White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol Scand 2002; 105:417.</a></li><li><a class="nounderline abstract_t">Tullberg M, Jensen C, Ekholm S, Wikkelsø C. Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR Am J Neuroradiol 2001; 22:1665.</a></li><li><a class="nounderline abstract_t">Krauss JK, Regel JP, Vach W, et al. White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: a comparative study. Neurosurgery 1997; 40:491.</a></li><li><a class="nounderline abstract_t">Krauss JK, Regel JP, Vach W, et al. Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting? Neurosurgery 1997; 40:67.</a></li><li><a class="nounderline abstract_t">Hakim R, Black PM. Correlation between lumbo-ventricular perfusion and MRI-CSF flow studies in idiopathic normal pressure hydrocephalus. Surg Neurol 1998; 49:14.</a></li><li><a class="nounderline abstract_t">Bradley WG Jr, Whittemore AR, Kortman KE, et al. Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus. Radiology 1991; 178:459.</a></li><li><a class="nounderline abstract_t">Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42:183.</a></li><li><a class="nounderline abstract_t">Holodny AI, Waxman R, George AE, et al. MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. AJNR Am J Neuroradiol 1998; 19:813.</a></li><li><a class="nounderline abstract_t">Savolainen S, Laakso MP, Paljärvi L, et al. MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis. AJNR Am J Neuroradiol 2000; 21:409.</a></li><li><a class="nounderline abstract_t">Halperin JJ, Kurlan R, Schwalb JM, et al. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2015; 85:2063.</a></li><li><a class="nounderline abstract_t">Malm J, Eklund A. Idiopathic normal pressure hydrocephalus. Practical Neurology 2006; 6:14.</a></li><li><a class="nounderline abstract_t">Wikkelsö C, Andersson H, Blomstrand C, et al. Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. Acta Neurol Scand 1986; 73:566.</a></li><li><a class="nounderline abstract_t">Walchenbach R, Geiger E, Thomeer RT, Vanneste JA. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002; 72:503.</a></li><li><a class="nounderline abstract_t">Kahlon B, Sundbärg G, Rehncrona S. Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002; 73:721.</a></li><li><a class="nounderline abstract_t">Malm J, Kristensen B, Karlsson T, et al. The predictive value of cerebrospinal fluid dynamic tests in patients with th idiopathic adult hydrocephalus syndrome. Arch Neurol 1995; 52:783.</a></li><li><a class="nounderline abstract_t">Lenfeldt N, Hansson W, Larsson A, et al. Three-day CSF drainage barely reduces ventricular size in normal pressure hydrocephalus. Neurology 2012; 79:237.</a></li><li><a class="nounderline abstract_t">Chen IH, Huang CI, Liu HC, Chen KK. Effectiveness of shunting in patients with normal pressure hydrocephalus predicted by temporary, controlled-resistance, continuous lumbar drainage: a pilot study. J Neurol Neurosurg Psychiatry 1994; 57:1430.</a></li><li><a class="nounderline abstract_t">Haan J, Thomeer RT. Predictive value of temporary external lumbar drainage in normal pressure hydrocephalus. Neurosurgery 1988; 22:388.</a></li><li><a class="nounderline abstract_t">Duinkerke A, Williams MA, Rigamonti D, Hillis AE. Cognitive recovery in idiopathic normal pressure hydrocephalus after shunt. Cogn Behav Neurol 2004; 17:179.</a></li><li><a class="nounderline abstract_t">Vanneste J, Augustijn P, Dirven C, et al. Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology 1992; 42:54.</a></li><li><a class="nounderline abstract_t">Graff-Radford NR. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology 2014; 83:1573.</a></li><li><a class="nounderline abstract_t">Savolainen S, Hurskainen H, Paljärvi L, et al. Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir (Wien) 2002; 144:515.</a></li><li><a class="nounderline abstract_t">Hamilton R, Patel S, Lee EB, et al. Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 2010; 68:535.</a></li><li><a class="nounderline abstract_t">Golomb J, Wisoff J, Miller DC, et al. Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry 2000; 68:778.</a></li><li><a class="nounderline abstract_t">Fisher CM. The clinical picture in occult hydrocephalus. Clin Neurosurg 1977; 24:270.</a></li><li><a class="nounderline abstract_t">Hughes CP, Siegel BA, Coxe WS, et al. Adult idiopathic communicating hydrocephalus with and without shunting. J Neurol Neurosurg Psychiatry 1978; 41:961.</a></li><li><a class="nounderline abstract_t">Toma AK, Papadopoulos MC, Stapleton S, et al. Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir (Wien) 2013; 155:1977.</a></li><li><a class="nounderline abstract_t">Kazui H, Miyajima M, Mori E, et al. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial. Lancet Neurol 2015; 14:585.</a></li><li><a class="nounderline abstract_t">Kanazawa R, Ishihara S, Sato S, et al. Familiarization with lumboperitoneal shunt using some technical resources. World Neurosurg 2011; 76:347.</a></li><li><a class="nounderline abstract_t">Nakajima M, Miyajima M, Ogino I, et al. Use of external lumbar cerebrospinal fluid drainage and lumboperitoneal shunts with Strata NSC valves in idiopathic normal pressure hydrocephalus: a single-center experience. World Neurosurg 2015; 83:387.</a></li><li><a class="nounderline abstract_t">Czosnyka Z, Czosnyka M, Richards HK, Pickard JD. Laboratory testing of hydrocephalus shunts -- conclusion of the U.K. Shunt evaluation programme. Acta Neurochir (Wien) 2002; 144:525.</a></li><li><a class="nounderline abstract_t">Ringel F, Schramm J, Meyer B. Comparison of programmable shunt valves vs standard valves for communicating hydrocephalus of adults: a retrospective analysis of 407 patients. Surg Neurol 2005; 63:36.</a></li><li><a class="nounderline abstract_t">Ziebell M, Wetterslev J, Tisell M, et al. Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus. Cochrane Database Syst Rev 2013; :CD009706.</a></li><li><a class="nounderline abstract_t">Boon AJ, Tans JT, Delwel EJ, et al. Dutch Normal-Pressure Hydrocephalus Study: randomized comparison of low- and medium-pressure shunts. J Neurosurg 1998; 88:490.</a></li><li><a class="nounderline abstract_t">Sæhle T, Farahmand D, Eide PK, et al. A randomized controlled dual-center trial on shunt complications in idiopathic normal-pressure hydrocephalus treated with gradually reduced or "fixed" pressure valve settings. J Neurosurg 2014; 121:1257.</a></li><li><a class="nounderline abstract_t">Farahmand D, Sæhle T, Eide PK, et al. A double-blind randomized trial on the clinical effect of different shunt valve settings in idiopathic normal pressure hydrocephalus. J Neurosurg 2016; 124:359.</a></li><li><a class="nounderline abstract_t">Weiner HL, Constantini S, Cohen H, Wisoff JH. Current treatment of normal-pressure hydrocephalus: comparison of flow-regulated and differential-pressure shunt valves. Neurosurgery 1995; 37:877.</a></li><li><a class="nounderline abstract_t">Pujari S, Kharkar S, Metellus P, et al. Normal pressure hydrocephalus: long-term outcome after shunt surgery. J Neurol Neurosurg Psychiatry 2008; 79:1282.</a></li><li><a class="nounderline abstract_t">Khan QU, Wharen RE, Grewal SS, et al. Overdrainage shunt complications in idiopathic normal-pressure hydrocephalus and lumbar puncture opening pressure. J Neurosurg 2013; 119:1498.</a></li><li><a class="nounderline abstract_t">Birkeland P, Lauritsen J, Poulsen FR. Aspirin is associated with an increased risk of subdural hematoma in normal-pressure hydrocephalus patients following shunt implantation. J Neurosurg 2015; 123:423.</a></li><li><a class="nounderline abstract_t">Malm J, Lundkvist B, Eklund A, et al. CSF outflow resistance as predictor of shunt function. A long-term study. Acta Neurol Scand 2004; 110:154.</a></li><li><a class="nounderline abstract_t">Raftopoulos C, Massager N, Balériaux D, et al. Prospective analysis by computed tomography and long-term outcome of 23 adult patients with chronic idiopathic hydrocephalus. Neurosurgery 1996; 38:51.</a></li></ol></div><div id="topicVersionRevision">Topic 5069 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28892572" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9330961" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Frequency of stages of Alzheimer-related lesions in different age categories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15057532" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Normal pressure hydrocephalus: survey on contemporary diagnostic algorithms and therapeutic decision-making in clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16008530" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : National and regional incidence of surgery for adult hydrocephalus in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21849644" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Normal pressure hydrocephalus: how often does the diagnosis hold water?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28293475" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: Epidemiological and clinical characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3974888" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Surgical treatment of idiopathic hydrocephalus in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3905156" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : CSF shunts for dementia, incontinence, and gait disturbance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24682964" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prevalence of idiopathic normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16028756" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2586776" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Symptomatic congenital hydrocephalus in the elderly simulating normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15195461" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Normal pressure hydrocephalus and large head size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15502119" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Is a large hat size hazardous to your health?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8553398" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3574694" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Idiopathic normal pressure hydrocephalus and systemic hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773072" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Vascular factors in suspected normal pressure hydrocephalus: A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773075" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Is normal pressure hydrocephalus becoming less idiopathic?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1899515" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23294486" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Do systolic BP and pulse pressure relate to ventricular enlargement?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11039335" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Normal pressure hydrocephalus: new concepts on etiology and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9347976" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Dutch normal-pressure hydrocephalus study: prediction of outcome after shunting by resistance to outflow of cerebrospinal fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10929729" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9055288" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Frontal brain and leptomeningeal biopsy specimens correlated with cerebrospinal fluid outflow resistance and B-wave activity in patients suspected of normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18570299" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Retrograde jugular flow associated with idiopathic normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11846911" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14303656" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931387" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Idiopathic normal pressure hydrocephalus: increased supplementary motor activity accounts for improvement after CSF drainage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/74511" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Communicating hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3827677" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Gait disorder in late-life hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11181848" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10567486" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2586777" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Variables predicting surgical outcome in symptomatic hydrocephalus in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3984674" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : [Prognostic factors for therapeutic outcome in normal-pressure hydrocephalus. Review of the literature and personal study].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25133881" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cerebrospinal fluid pressure in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23758953" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6625987" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Gait disorders among elderly patients. A survey study of 50 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10797583" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3741212" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Normal-pressure hydrocephalus. Onset of gait abnormality before dementia predicts good surgical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21235310" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Shunt surgery in patients with hydrocephalus and white matter changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15908748" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Association between cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/304535" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Measurements of the normal ventricular system and hemispheric sulci of 100 adults with computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/988505" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Changes in size of normal lateral ventricles during aging determined by computerized tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7359191" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3767314" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prognosis of dementia in normal-pressure hydrocephalus after a shunt operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7066675" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The predictive value of conductance to outflow of CSF in normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9726467" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21040519" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28156249" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Utility of MRI-based disproportionately enlarged subarachnoid space hydrocephalus scoring for predicting prognosis after surgery for idiopathic normal pressure hydrocephalus: clinical research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23183074" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Guidelines for management of idiopathic normal pressure hydrocephalus: second edition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10701891" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Diagnosis and management of normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8832666" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9950492" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Dutch Normal-Pressure Hydrocephalus Study: the role of cerebrovascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12027829" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11673159" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9055287" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: a comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8971826" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9428889" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Correlation between lumbo-ventricular perfusion and MRI-CSF flow studies in idiopathic normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1987609" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1734300" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9613493" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10696032" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26644048" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Idiopathic normal pressure hydrocephalus</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3751498" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11909911" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12438477" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7639630" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The predictive value of cerebrospinal fluid dynamic tests in patients with th idiopathic adult hydrocephalus syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22764254" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Three-day CSF drainage barely reduces ventricular size in normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7964828" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effectiveness of shunting in patients with normal pressure hydrocephalus predicted by temporary, controlled-resistance, continuous lumbar drainage: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3352890" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Predictive value of temporary external lumbar drainage in normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15536306" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Cognitive recovery in idiopathic normal pressure hydrocephalus after shunt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1734324" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25332445" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12111484" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20687117" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10811706" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/583685" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The clinical picture in occult hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/309503" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Adult idiopathic communicating hydrocephalus with and without shunting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23975646" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25934242" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21986435" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Familiarization with lumboperitoneal shunt using some technical resources.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25108293" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Use of external lumbar cerebrospinal fluid drainage and lumboperitoneal shunts with Strata NSC valves in idiopathic normal pressure hydrocephalus: a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12111485" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Laboratory testing of hydrocephalus shunts -- conclusion of the U.K. Shunt evaluation programme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15639519" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Comparison of programmable shunt valves vs standard valves for communicating hydrocephalus of adults: a retrospective analysis of 407 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23728696" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9488303" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Dutch Normal-Pressure Hydrocephalus Study: randomized comparison of low- and medium-pressure shunts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25192478" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A randomized controlled dual-center trial on shunt complications in idiopathic normal-pressure hydrocephalus treated with gradually reduced or "fixed" pressure valve settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26315004" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A double-blind randomized trial on the clinical effect of different shunt valve settings in idiopathic normal pressure hydrocephalus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8559335" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Current treatment of normal-pressure hydrocephalus: comparison of flow-regulated and differential-pressure shunt valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18356257" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Normal pressure hydrocephalus: long-term outcome after shunt surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23930853" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Overdrainage shunt complications in idiopathic normal-pressure hydrocephalus and lumbar puncture opening pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25555087" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Aspirin is associated with an increased risk of subdural hematoma in normal-pressure hydrocephalus patients following shunt implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15285771" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : CSF outflow resistance as predictor of shunt function. A long-term study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8747951" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Prospective analysis by computed tomography and long-term outcome of 23 adult patients with chronic idiopathic hydrocephalus.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
